Immunohistochemical expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in invasive breast carcinoma
Svjetlana Radović
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences, 2009
View PDFchevron_right
Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family
Gem khyle Velasco
Cancer research, 1994
View PDFchevron_right
Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma
Mads Holten-Andersen
International Journal of Cancer, 2005
View PDFchevron_right
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome
Eleni Mylona
Breast Cancer …, 2006
View PDFchevron_right
Inhibition of tumor promoter activity toward mouse fibroblasts and their in vitro transformation by tissue inhibitor of metalloproteinases- 1 (TIMP-1)
shoji azuma
Carcinogenesis, 1997
View PDFchevron_right
Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression
Elise Lambert
Biochimie, 2005
View PDFchevron_right
MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours
Radislav Sedlacek
The Journal of Pathology, 2001
View PDFchevron_right
Down-Regulation of Vascular Endothelial Growth Factor by Tissue Inhibitor of Metalloproteinase-2: Effect on in Vivo Mammary Tumor Growth and Angiogenesis1
Nor Eddine Sounni
2001
View PDFchevron_right
Comparative study of the immunohistochemical expression of tissue inhibitors of metalloproteinases 1 and 2 between clearly invasive carcinomas and “in situ” trophoblast invasion
Aphrodite Nonni
Medical Oncology, 2011
View PDFchevron_right
Is the expression of matrix metalloproteinases (MMP-2, -9) and tissue inhibitors of metalloproteinases (TIMP-1, -2, and -3) associated with angiogenesis and clinicopathological features for breast cancer
Journal of Health Sciences
View PDFchevron_right
Expression of metalloproteases and their inhibitors in different histological types of breast cancer
Fernanda Garcia
Journal of Cancer Research and Clinical Oncology, 2010
View PDFchevron_right
Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp-2 in neoplastic tissues with monclonal antibodies
William g. Stetler-stevenson
International Journal of Cancer, 1994
View PDFchevron_right
Enhanced Immunoreactivity of TIMP-2 in the Stromal Compartment of Tumor as a Marker of Favorable Prognosis in Ovarian Cancer Patients
Rafał Matkowski
Journal of Histochemistry & Cytochemistry, 2012
View PDFchevron_right
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
Ben Davidson
European Journal of Cancer, 2001
View PDFchevron_right
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
O. Fodstad
Clinical cancer research : an official journal of the American Association for Cancer Research, 1997
View PDFchevron_right
Upstream Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Element-1, a Novel and Essential Regulatory DNA Motif in the Human TIMP-1 Gene Promoter, Directly Interacts with a 30-kDa Nuclear Protein
satinder samra
Journal of Biological Chemistry, 2000
View PDFchevron_right
Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells
J. Lunec
European Journal of Cancer, 1996
View PDFchevron_right
Expression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and TIMP-3 protein in invasive breast carcinoma: correlations with prognostic factors
Christina Magkou
Biomedicine & Pharmacotherapy, 2008
View PDFchevron_right
Expression of tissue inhibitors of metalloproteinase 1 (TIMP-1) in gastric cancer tissue
Magdalena Groblewska
Folia Histochemica Et Cytobiologica, 2009
View PDFchevron_right
Increased Expression of Tissue Inhibitor of Metalloproteinases Type 1 (TIMP‐1) In a More Tumourigenic Colon Cancer Cell Line
J. Bousquet
The Journal of …, 2000
View PDFchevron_right
Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells
Robert Mansel
International Journal of Molecular Medicine, 2006
View PDFchevron_right
Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast
Rosario Sanchez
Histopathology, 2008
View PDFchevron_right
Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas
Luis González
Breast Cancer Research and Treatment, 2009
View PDFchevron_right
Gelatin Zymography and Substrate Cleavage Assays of Matrix Metalloproteinase-2 in Breast Carcinoma Cells Overexpressing Membrane Type-1 Matrix Metalloproteinase
Elena Deryugina
Laboratory Investigation, 2002
View PDFchevron_right
Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer
Luis González
Journal of Cancer Research and Clinical Oncology, 2010
View PDFchevron_right
Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 in Breast Cancer
John Mackey
International Journal of Breast Cancer, 2012
View PDFchevron_right